0001493152-20-016100.txt : 20200817
0001493152-20-016100.hdr.sgml : 20200817
20200817163032
ACCESSION NUMBER: 0001493152-20-016100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200817
DATE AS OF CHANGE: 20200817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karkus Ted William
CENTRAL INDEX KEY: 0001457896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 201110571
MAIL ADDRESS:
STREET 1: 188 HEWLETT NECK ROAD
CITY: WOODMERE
STATE: NY
ZIP: 11598
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
BUSINESS PHONE: 2153450919
MAIL ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2020-08-13
0
0000868278
ProPhase Labs, Inc.
PRPH
0001457896
Karkus Ted William
621 N. SHADY RETREAT ROAD
DOYLESTOWN
PA
18901
1
1
1
0
CEO & CHAIRMAN
Common Stock, par value $0.005
2020-08-13
4
S
0
50000
2.75
D
2419528
D
Common Stock, par value $0.005
40000
I
By Son
Common Stock, par value $0.005
40000
I
By Son
These shares were sold in a private transaction to Louis Gleckel, a director of the Issuer, pursuant to the terms of a Stock Purchase Agreement.
/s/ Ted Karkus
2020-08-17